Advertisement

Risk factors associated with interfacility transfers among patients with Clostridium difficile infection

      Background

      Preventing the transmission of Clostridium difficile infection (CDI) over the continuum of care presents an important challenge for infection control.

      Methods

      A prospective case-control study was conducted on patients admitted with CDI to a tertiary care hospital in Detroit between August 2012 and September 2013. Patients were then followed for 1 year by telephone interviews and the hospital administrative database. Cases, patients with interfacility transfers (IFTs), were patients admitted to our facility from another health care facility and discharged to long-term care (LTC) facilities. Controls were patients admitted from and discharged to home.

      Results

      There were 143 patients included in the study. Thirty-six (30%) cases were compared with 84 (70%) controls. Independent risk factors of CDI patients with IFTs (compared with CDI patients without IFTs) included Charlson Comorbidity Index score ≥6 (odds ratio [OR], 5.30; P = .016) and hospital-acquired CDI (OR, 4.92; P = .023). Patients with IFTs were more likely to be readmitted within 90 days of discharge than patients without IFTs (OR, 2.24; P = .046). One-year mortality rate was significantly higher among patients with IFTs than among patients without IFTs (OR, 4.33; P = .01).

      Conclusions

      With the growing number of alternate health care centers, it is highly critical to establish better collaboration between acute care and LTC facilities to tackle the increasing burden of CDI across the health care system.

      Key Words

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lessa F.C.
        • Mu Y.
        • Bamberg W.M.
        • Beldavs Z.G.
        • Dumyati G.K.
        • Dunn J.R.
        • et al.
        Burden of Clostridium difficile infection in the United States.
        N Engl J Med. 2015; 372: 825-834
        • Ricciardi R.
        • Rothenberger D.A.
        • Madoff R.D.
        • Baxter N.N.
        Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States.
        Arch Surg. 2007; 142 (discussion 631): 624-631
        • McDonald L.C.
        • Owings M.
        • Jernigan D.B.
        Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003.
        Emerg Infect Dis. 2006; 12: 409-415
        • Kelly C.P.
        • LaMont J.T.
        Clostridium difficile—more difficult than ever.
        N Engl J Med. 2008; 359: 1932-1940
        • Blossom D.B.
        • McDonald L.C.
        The challenges posed by reemerging Clostridium difficile infection.
        Clin Infect Dis. 2007; 45: 222-227
        • Dubberke E.R.
        • Reske K.A.
        • Yan Y.
        • Olsen M.A.
        • McDonald L.C.
        • Fraser V.J.
        Clostridium difficile–associated disease in a setting of endemicity: identification of novel risk factors.
        Clin Infect Dis. 2007; 45: 1543-1549
        • Gravel D.
        • Miller M.
        • Simor A.
        • Taylor G.
        • Gardam M.
        • McGeer A.
        • et al.
        Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study.
        Clin Infect Dis. 2009; 48: 568-576
        • Kossovsky M.P.
        • Sarasin F.P.
        • Chopard P.
        • Louis-Simonet M.
        • Sigaud P.
        • Perneger T.V.
        • et al.
        Relationship between hospital length of stay and quality of care in patients with congestive heart failure.
        Qual Saf Health Care. 2002; 11: 219-223
        • Clarke A.
        Length of in-hospital stay and its relationship to quality of care.
        Qual Saf Health Care. 2002; 11: 209-210
        • Jones A.L.
        • Dwyer L.L.
        • Bercovitz A.R.
        • Strahan G.W.
        The National Nursing Home Survey: 2004 overview.
        Vital Health Stat 13. 2009; : 1-155
        • Bootsma M.C.
        • Diekmann O.
        • Bonten M.J.
        Controlling methicillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing.
        Proc Natl Acad Sci USA. 2006; 103: 5620-5625
        • Cohen S.H.
        • Gerding D.N.
        • Johnson S.
        • Kelly C.P.
        • Loo V.G.
        • McDonald L.C.
        • et al.
        Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA).
        Infect Control Hosp Epidemiol. 2010; 31: 431-455
        • Huang S.S.
        • Avery T.R.
        • Song Y.
        • Elkins K.R.
        • Nguyen C.C.
        • Nutter S.K.
        • et al.
        Quantifying interhospital patient sharing as a mechanism for infectious disease spread.
        Infect Control Hosp Epidemiol. 2010; 31: 1160-1169
        • Gerding D.N.
        • Olson M.M.
        • Peterson L.R.
        • Teasley D.G.
        • Gebhard R.L.
        • Schwartz M.L.
        • et al.
        Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study.
        Arch Intern Med. 1986; 146: 95-100
        • Charlson M.
        • Szatrowski T.P.
        • Peterson J.
        • Gold J.
        Validation of a combined comorbidity index.
        J Clin Epidemiol. 1994; 47: 1245-1251
        • McCabe W.R.
        • Jackson G.
        Gram-negative bacteremia: I. Etiology and ecology.
        Arch Intern Med. 1962; 110: 847-855
        • Katz S.
        Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living.
        J Am Geriatr Soc. 1983; 31: 721-727
        • McDonald L.C.
        • Coignard B.
        • Dubberke E.
        • Song X.
        • Horan T.
        • Kutty P.K.
        • et al.
        Recommendations for surveillance of Clostridium difficile-associated disease.
        Infect Control Hosp Epidemiol. 2007; 28: 140-145
        • Noren T.
        • Alriksson I.
        • Andersson J.
        • Akerlund T.
        • Unemo M.
        Rapid and sensitive loop-mediated isothermal amplification test for Clostridium difficile detection challenges cytotoxin B cell test and culture as gold standard.
        J Clin Microbiol. 2011; 49: 710-711
        • Khanna S.
        • Pardi D.S.
        • Aronson S.L.
        • Kammer P.P.
        • Orenstein R.
        • St Sauver J.L.
        • et al.
        The epidemiology of community-acquired Clostridium difficile infection: a population-based study.
        Am J Gastroenterol. 2012; 107: 89-95
        • Centers for Disease Control and Prevention (CDC)
        Severe Clostridium difficile-associated disease in populations previously at low risk—four states, 2005.
        MMWR Morb Mortal Wkly Rep. 2005; 54: 1201-1205
        • Centers for Disease Control and Prevention (CDC)
        Surveillance for community-associated Clostridium difficile—Connecticut, 2006.
        MMWR Morb Mortal Wkly Rep. 2008; 57: 340-343
        • Kutty P.K.
        • Benoit S.R.
        • Woods C.W.
        • Sena A.C.
        • Naggie S.
        • Frederick J.
        • et al.
        Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005.
        Infect Control Hosp Epidemiol. 2008; 29: 197-202
        • Garg S.
        • Mirza Y.R.
        • Girotra M.
        • Kumar V.
        • Yoselevitz S.
        • Segon A.
        • et al.
        Epidemiology of Clostridium difficile-associated disease (CDAD): a shift from hospital-acquired infection to long-term care facility-based infection.
        Dig Dis Sci. 2013; 58: 3407-3412
        • Kim J.H.
        • Toy D.
        • Muder R.R.
        Clostridium difficile infection in a long-term care facility: hospital-associated illness compared with long-term care-associated illness.
        Infect Control Hosp Epidemiol. 2011; 32: 656-660
        • Guerrero D.M.
        • Nerandzic M.M.
        • Jury L.A.
        • Chang S.
        • Jump R.L.
        • Donskey C.J.
        Clostridium difficile infection in a Department of Veterans Affairs long-term care facility.
        Infect Control Hosp Epidemiol. 2011; 32: 513-515
        • Ricciardi R.
        • Nelson J.
        • Griffith J.L.
        • Concannon T.W.
        Do admissions and discharges to long-term care facilities influence hospital burden of Clostridium difficile infection?.
        J Hosp Infect. 2012; 80: 156-161
        • Jinno S.
        • Kundrapu S.
        • Guerrero D.M.
        • Jury L.A.
        • Nerandzic M.M.
        • Donskey C.J.
        Potential for transmission of Clostridium difficile by asymptomatic acute care patients and long-term care facility residents with prior C. difficile infection.
        Infect Control Hosp Epidemiol. 2012; 33: 638-639
        • Smith P.W.
        • Bennett G.
        • Bradley S.
        • Drinka P.
        • Lautenbach E.
        • Marx J.
        • et al.
        SHEA/APIC Guideline: infection prevention and control in the long-term care facility.
        Am J Infect Control. 2008; 36: 504-535
        • Castle S.
        • Uyemura K.
        • Wong W.
        • Modlin R.
        • Effros R.
        Evidence of enhanced type 2 immune response and impaired upregulation of a type 1 response in frail elderly nursing home residents.
        Mech Ageing Dev. 1997; 94: 7-16
        • Simor A.E.
        Diagnosis, management, and prevention of Clostridium difficile infection in long-term care facilities: a review.
        J Am Geriatr Soc. 2010; 58: 1556-1564